EAGLE PHARMACEUTICALS INC's ticker is and the CUSIP is 269796908. A total of 3 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 100 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $1,923,000 | +161.6% | 32,000 | +146.2% | 0.01% | +116.7% |
| Q3 2019 | $735,000 | -48.9% | 13,000 | -49.6% | 0.01% | -53.8% |
| Q2 2019 | $1,437,000 | +851.7% | 25,800 | +760.0% | 0.01% | +550.0% |
| Q1 2019 | $151,000 | -58.4% | 3,000 | -66.7% | 0.00% | -33.3% |
| Q4 2018 | $363,000 | -84.9% | 9,000 | -74.1% | 0.00% | -84.2% |
| Q3 2018 | $2,406,000 | +28.7% | 34,700 | +40.5% | 0.02% | +18.8% |
| Q2 2018 | $1,869,000 | +47.2% | 24,700 | +2.5% | 0.02% | +23.1% |
| Q1 2018 | $1,270,000 | +317.8% | 24,100 | +322.8% | 0.01% | +550.0% |
| Q4 2017 | $304,000 | -82.0% | 5,700 | -79.9% | 0.00% | -86.7% |
| Q3 2017 | $1,688,000 | -61.3% | 28,300 | -48.8% | 0.02% | -66.7% |
| Q2 2017 | $4,363,000 | +369.6% | 55,300 | +393.8% | 0.04% | +309.1% |
| Q1 2017 | $929,000 | +11512.5% | 11,200 | +11100.0% | 0.01% | – |
| Q4 2016 | $8,000 | -42.9% | 100 | -50.0% | 0.00% | – |
| Q3 2016 | $14,000 | -98.1% | 200 | -98.9% | 0.00% | -100.0% |
| Q2 2016 | $725,000 | -0.5% | 18,700 | +3.9% | 0.01% | -10.0% |
| Q1 2016 | $729,000 | +64.6% | 18,000 | +260.0% | 0.01% | +100.0% |
| Q4 2015 | $443,000 | +5.0% | 5,000 | -12.3% | 0.01% | -16.7% |
| Q3 2015 | $422,000 | +5175.0% | 5,700 | +5600.0% | 0.01% | – |
| Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 2,900 | $234,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3 | $1,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $8,000 | 0.00% |